Journal of Medicinal Chemistry 2005

8 papers
The 2005 edition of the Journal of Medicinal Chemistry emphasized structural biology and computational methodologies in drug discovery. Research themes included the development of kinase inhibitors, specifically examining the structural basis of inhibitor specificity in the human protooncogene PIM-1. Authors such as Thierry Langer, Alex N. Bullock, and Stefan Knapp contributed to studies utilizing pharmacophore modeling, virtual screening, and molecular dynamics to identify ligands for the sigma-1 receptor and design selective histone deacetylase (HDAC) inhibitors. Additional work explored the use of computer-assisted approaches, including docking and principal component analysis, to target the human rhinovirus coat protein. Synthetic efforts during this year also produced new iminosugar derivatives as potential immunosuppressive agents and 1H-imidazoles as ligands for the estrogen receptor and cyclooxygenase inhibitors. These contributions reflect a trend toward integrating molecular simulation with synthetic chemistry to refine inhibitor selectivity and potency across various therapeutic targets.

Top Research Directions

The 6 research directions with Journal of Medicinal Chemistry 2005 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Modeling Induced Fit in Structure Based Drug Design112.5%
2Modeling Molecular Dynamics Beyond Static Structural Snapshots112.5%
3Predicting Ligand Protein Binding via Molecular Docking112.5%
4Structural Determinants of Receptor Subtype Selectivity112.5%
5Template-Based Protein Structure Prediction112.5%
6The Reliability Gap in Molecular Scoring Functions112.5%

Download all directions as CSV

Institutions

Institutions credited by Journal of Medicinal Chemistry 2005 papers: a paper credits every institution named in its affiliations, once. 2 institutions share 1 credited papers.

#InstitutionPapersShare
1009yjbg58 1100.0%
2University of Notre Dame 1100.0%

Download all institutions as CSV

About this data

Papers. Journal of Medicinal Chemistry 2005 lists 8 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 8 papers (12.5%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Medicinal Chemistry 2005”, https://lacuna.tiptreesystems.com/venue/journal-of-medicinal-chemistry/2005.

Top Authors

AuthorPapers
Thierry Langer3
Brian Marsden1

Impactful Papers

Papers from Journal of Medicinal Chemistry 2005 that shaped research clusters.

Foundational

Influential

Papers

Title
Discovery of High-Affinity Ligands of σ1 Receptor, ERG2, and Emopamil Binding Protein by Pharmacophore Modeling and Virtual Screening
Pharmacophore Modeling, Docking, and Principal Component Analysis Based Clustering: Combined Computer-Assisted Approaches To Identify New Inhibitors of the Human Rhinovirus Coat Protein
Pharmacophore Modeling, Docking, and Principal Component Analysis Based Clustering:  Combined Computer-Assisted Approaches To Identify New Inhibitors of the Human Rhinovirus Coat Protein
Structural Basis of Inhibitor Specificity of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia Virus (PIM-1) Kinase
Synthesis and Pharmacological Evaluation of 1H-Imidazoles as Ligands for the Estrogen Receptor and Cytotoxic Inhibitors of the Cyclooxygenase
Synthetic Iminosugar Derivatives as New Potential Immunosuppressive Agents
Toward Selective Histone Deacetylase Inhibitor Design: Homology Modeling, Docking Studies, and Molecular Dynamics Simulations of Human Class I Histone Deacetylases
Toward Selective Histone Deacetylase Inhibitor Design:  Homology Modeling, Docking Studies, and Molecular Dynamics Simulations of Human Class I Histone Deacetylases